Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Can Fam Physician ; 52: 612-8, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16739835

RESUMO

OBJECTIVE: To review treatment recommendations for empiric therapy of uncomplicated urinary tract infection (uUTI) in light of evolving antibiotic resistance and to consider use of guidelines to promote optimal practice. QUALITY OF EVIDENCE: PubMed was searched and additional relevant references were identified by reviewing articles found in the search. Guidelines were identified through discussion with family practitioners. Level of evidence was assessed for recommendations. MAIN MESSAGE: Many women have uUTIs. The treatment approach is usually empiric antimicrobial therapy without obtaining pretherapy cultures. Trimethoprim-sulfamethoxazole is standard first-line empiric treatment. While resistance to this drug is increasing, it remains only about 10% in community-acquired Escherichia coli in Canada. Concerns about increased resistance have contributed to greater use of fluoroquinolones, but widespread empiric use of this class of medications might promote resistance to fluoroquinolones. Hence, fluoroquinolones should not be considered first-line therapy. While guidelines for treatment of uUTIs have been developed, their usefulness is compromised by their conflicting recommendations. CONCLUSION: Trimethoprim-sulfamethoxazole and nitrofurantoin remain first-choice empiric therapy for uUTIs. Development of guidelines relevant to family physicians and community education programs that incorporate local susceptibility patterns are important strategies for promoting optimal practice.


Assuntos
Anti-Infecciosos Urinários/uso terapêutico , Farmacorresistência Bacteriana , Infecções Urinárias/tratamento farmacológico , Anti-Infecciosos Urinários/efeitos adversos , Anti-Infecciosos Urinários/farmacologia , Combinação de Medicamentos , Feminino , Fluoroquinolonas/efeitos adversos , Fluoroquinolonas/farmacologia , Fluoroquinolonas/uso terapêutico , Humanos , Nitrofurantoína/efeitos adversos , Nitrofurantoína/farmacologia , Nitrofurantoína/uso terapêutico , Guias de Prática Clínica como Assunto , Sulfametizol/efeitos adversos , Sulfametizol/farmacologia , Sulfametizol/uso terapêutico , Trimetoprima/efeitos adversos , Trimetoprima/farmacologia , Trimetoprima/uso terapêutico , Infecções Urinárias/microbiologia
2.
J Obstet Gynaecol Can ; 27(11): 1027-30, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16529670

RESUMO

BACKGROUND: Primary carcinoma of the rectovaginal septum is very rare. Most cases are associated with documented endometriosis, and patients will often present with vaginal or rectal bleeding. CASE: A 47-year-old woman presented to the emergency department complaining of urinary symptoms and "something falling out of the vagina." She was diagnosed initially as having uterine prolapse. However, further investigations and surgery showed that she had a primary papillary serous carcinoma of the rectovaginal septum, and the carcinoma later metastasized to the lymph nodes. No evidence of endometriosis was found. Assessment and subsequent treatment of this aggressive tumour was likely delayed because of its initial benign presentation. CONCLUSION: Our presentation of the case of a woman with primary carcinoma of the rectovaginal septum not associated with a focus of endometriosis shows that this rare aggressive cancer may present in a clinically benign fashion.


Assuntos
Carcinoma Papilar/diagnóstico , Neoplasias Retais/diagnóstico , Prolapso Uterino/diagnóstico , Neoplasias Vaginais/diagnóstico , Carcinoma Papilar/patologia , Carcinoma Papilar/secundário , Diagnóstico Diferencial , Evolução Fatal , Feminino , Humanos , Metástase Linfática , Pessoa de Meia-Idade , Neoplasias Retais/patologia , Prolapso Uterino/patologia , Neoplasias Vaginais/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...